Taken together, the high prevalence of sicca symptoms and anti-Ro/SSA antibodies suggests that secondary or associated Sjögren syndrome might be as common in IPAF as in patients with other specific CTD (eg, RA).18 This evidence concerns the gene TRIM21 and Sjogren syndrome.